Marie Klintman

530 total citations
20 papers, 355 citations indexed

About

Marie Klintman is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Marie Klintman has authored 20 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Marie Klintman's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (9 papers) and Breast Lesions and Carcinomas (6 papers). Marie Klintman is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (9 papers) and Breast Lesions and Carcinomas (6 papers). Marie Klintman collaborates with scholars based in Sweden, Denmark and United Kingdom. Marie Klintman's co-authors include Pär‐Ola Bendahl, Dorthe Grabau, Mårten Fernö, Per Malmström, Kristina Lövgren, Mitch Dowsett, Signe Borgquist, Lisa Rydén, Niklas Loman and Christian Ingvar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Marie Klintman

19 papers receiving 347 citations

Peers

Countries citing papers authored by Marie Klintman

Since Specialization

Citations

This map shows the geographic impact of Marie Klintman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Klintman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Klintman more than expected).

Fields of papers citing papers by Marie Klintman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Klintman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Klintman. The network helps show where Marie Klintman may publish in the future.

Co-authorship network of co-authors of Marie Klintman

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Klintman. A scholar is included among the top collaborators of Marie Klintman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Klintman. Marie Klintman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics 2023 ·Frontiers in Oncology ·(unknown), Marie Klintman, Johan Vallon‐Christersson, Sophia Zackrisson, Per Hall, Signe Borgquist, Ann H. Rosendahl	1
2	Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Deirdre Cronin‐Fenton, Marie Klintman, Susanne Oksbjerg Dalton, Ann H. Rosendahl, Signe Borgquist	10
3	Postmenopausal overweight and breast cancer risk; results from the KARMA cohort 2022 ·Breast Cancer Research and Treatment ·Marie Klintman, Ann H. Rosendahl, (unknown), Mikael Eriksson, Kamila Czene, Per Hall, Signe Borgquist	14
4	Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer Study 2022 ·Cancers ·(unknown), Marie Klintman, Ann H. Rosendahl	9
5	Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0) 2020 ·JNCI Cancer Spectrum ·(unknown), Jonas Höijer, Linnea Widman, Johan Ahlgren, Lars-Gunnar Arnesson, Zakaria Einbeigi, Marie Klintman, (unknown), Malin Sund, Irma Fredriksson, Jonas Bergh, (unknown)	3
6	Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer 2020 ·npj Breast Cancer ·Christer Larsson, Anna Ehinger, Sofia Winslow, Karin Leandersson, Marie Klintman, Ludvig Dahl, Johan Vallon‐Christersson, Jari Häkkinen, Cecilia Hegardt, Jonas Manjer, Lao H. Saal, Lisa Rydén, Martin Malmberg, Åke Borg, Niklas Loman	29
7	Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer 2019 ·Breast Cancer Research and Treatment ·(unknown), Pär‐Ola Bendahl, Åke Borg, Anna Ehinger, Cecilia Hegardt, Christer Larsson, Niklas Loman, Martin Malmberg, Helena Olofsson, Lao H. Saal, Tobias Sjöblom, Henrik Lindman, Marie Klintman, Jari Häkkinen, Johan Vallon‐Christersson, Mårten Fernö, Lisa Rydén, Maria Ekholm	20
8	Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer 2018 ·Breast Cancer Research ·Richard Buus, Belinda Yeo, Adam R. Brentnall, Marie Klintman, Maggie C.U. Cheang, Komel Khabra, Ivana Šestak, Qiong Gao, Jack Cuzick, Mitch Dowsett	7
9	Androgen Receptor in Stage I-II Primary Breast Cancer –Prognostic Value and Distribution in Subgroups 2017 ·Anticancer Research ·Emma Niméus, (unknown), Björn Nodin, Linda Hartman, Marie Klintman	6
10	Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease 2016 ·Clinical Cancer Research ·Marie Klintman, Richard Buus, Maggie C.U. Cheang, Amna Sheri, Ian E. Smith, Mitch Dowsett	38
11	Early Surrogate Markers of Treatment Activity: Where Are We Now? 2015 ·JNCI Monographs ·Marie Klintman, Mitch Dowsett	12
12	Abstract 5294: Biomarkers in residual disease after neoadjuvant chemotherapy of breast cancer predict long-term outcome 2015 ·Cancer Research ·Richard Buus, Marie Klintman, Amna Sheri, Maggie C.U. Cheang, Mitch Dowsett	1
13	The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer 2013 ·PLoS ONE ·Marie Klintman, Carina Strand, Cecilia Ahlin, (unknown), Marie-Louise Fjällskog, Dorthe Grabau, Einar Gudlaugsson, Emiel A. M. Janssen, Kristina Lövgren, Ivar Skaland, Pär‐Ola Bendahl, Per Malmström, Jan P. A. Baak, Mårten Fernö	24
14	A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial 2013 ·Annals of Oncology ·Marie Klintman, Fredrik Nilsson, Pär‐Ola Bendahl, Mårten Fernö, (unknown), Stefan O. Emdin, P. Malmström	4
15	The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer 2013 ·SpringerPlus ·Carina Strand, Martin Bak, Signe Borgquist, Gunilla Chebil, (unknown), Marie-Louise Fjällskog, Dorthe Grabau, Ingrid Hedenfalk, Karin Jirström, Marie Klintman, Per Malmström, Hans Olsson, Lisa Rydén, Olle Stål, Pär‐Ola Bendahl, Mårten Fernö	12
16	Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies 2011 ·BMC Cancer ·(unknown), Pär‐Ola Bendahl, Marie Klintman, Niklas Loman, Christian Ingvar, Lisa Rydén, Carsten Rose, Dorthe Grabau, Signe Borgquist	70
17	The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer 2009 ·Modern Pathology ·Marie Klintman, Pär‐Ola Bendahl, Dorthe Grabau, Kristina Lövgren, Per Malmström, Mårten Fernö	73
18	Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer 2009 ·Breast Cancer Research and Treatment ·Marie Klintman, Sidse Ørnbjerg Würtz, Ib Jarle Christensen, (unknown), Mårten Fernö, Martin Malmberg, Henning T. Mouridsen, Frederik Cold, Anne‐Sofie Schrohl, John A. Foekens, Per‐Uno Malmström, Nils Brünner	14
19	Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer. 2009 ·Cancer Research ·Sidse Ørnbjerg Würtz, Marie Klintman, (unknown), (unknown), M Fernö, Martin Malmberg, Henning T. Mouridsen, Frederik Cold, Anne‐Sofie Schrohl, J.A. Foekens, Johan Malmström, N. Brünner	1
20	Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer. 2009 ·Cancer Research ·(unknown), Marie Klintman, Dorthe Grabau, Pär‐Ola Bendahl, Mårten Fernö, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact